Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD
Crossref DOI link: https://doi.org/10.1186/s12890-016-0266-5
Published Online: 2016-07-20
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Beier, Jutta
Pujol, Helena
Seoane, Beatriz
Jimenez, Eulalia
Astbury, Carol
Massana, Eric
Ruiz, Sandrine
de Miquel, Gonzalo
License valid from 2016-07-20